Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-22-001343
Filing Date
2022-08-18
Accepted
2022-08-18 17:00:20
Documents
2
Group Members
JEFF EASTONLIND GLOBAL PARTNERS II LLC

Document Format Files

Seq Description Document Type Size
1 sched13g.htm SC 13G 67656
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 7834
  Complete submission text file 0000929638-22-001343.txt   77254
Mailing Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008
Business Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008 (858) 704-4900
PALISADE BIO, INC. (Subject) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86724 | Film No.: 221178045
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022 646-701-7428
Lind Global Fund II LP (Filed by) CIK: 0001871665 (see all company filings)

EIN.: 863914253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G